Christian Meyer

@Dr_Lori_Burrows Thanks Dr Burrows. Big fan of your work. Hope this approach can increase the scale of viability experiments you consider.

It’s the little things…🤯

@sciliz Glad you enjoyed it! Let us know how we can help you get it working in your lab.

@SaranDavies Hi Saran. This is Christian the lead author on the paper. We have had good success matching MIC measurements of broth micro dilution assays to GVA-based MIC by adding the drug directly in the pipette tip. As a bonus, you can measure the degree of heteroresistance in a sample.

Would be awesome to see how this worked for antibiotic susceptibility testing. Also great to reduce waste in the lab 👏

OUT NOW A High Throughput and Low Waste Viability Assay for Microbes by @meyerct6 @danastamo nature.com/articles/s4156…

@gwayscience Thanks @gwayscience for the press. Very much enjoyed your talk yesterday!

Next up at #MPDD is @meyerct6 discussing MuSyC They have a webapp musyc.lolab.xyz

Pleased to share our preprint on bacterial zombies! These zombie cells are non-viable but they reshape the antibiotic tolerance of other species via paracrine secretions. Great working with @kralj_lab alumni @BruniGN and Ben. @BioFrontiers @CUBoulder biorxiv.org/content/10.110…

Thanks for the shout out!

.@meyerct6 @quarantalab @ceelox4 @AlexLubbock present #MuSyC, a consensus synergy metric for characterizing combinatorial drug interactions. #MuSyC overcomes several caveats associated with popular synergy metrics. go.nature.com/2VxQTNE

@NatureComms @quarantalab @ceelox4 @AlexLubbock Thanks to @NatureComms for their professional and outstanding help in writing this next chapter of drug synergy studies #MuSyC

Woo! Finally. Check out our paper: MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery, w/ @quarantalab #NSFfunded #NIHfunded #whatweneedmoreofistheory rdcu.be/cqKIo

Happy to share our paper online today at Cytometry A describing DebarcodeR - an algorithm for demultiplexing fluorescence cell barcoded (FCB) flow cytometry data. (1/12) @jonathanirish @BrianOBachmann onlinelibrary.wiley.com/doi/10.1002/cy…

Great example of the impact of undergraduate research @CUBoulder. Congrats Eugene Miller @eugenejoemiller for getting published as an undergraduate!

New work from @BioFrontiers on machine learning applied to detecting antibiotic sensitivity. Thanks to Joel Kralj, Megan Jewel, and @eugenejomiller! Machine Learning Establishes Single-Cell Calcium Dynamics as an Early Indicator of Antibiotic Response mdpi.com/1098518

A Bayesian framework for intelligently deploying universal COVID testing: disq.us/t/3wgezdl Related to the recent, fantastic article by @TomChivers in @guardian theguardian.com/world/2021/apr…

This week in the field of mathematical oncology: issue 105. <glioblastoma models, drug synergistic effects, the cancer microbiome, organoid dynamics> buff.ly/3atSpCC

Really nice overview by the @quarantalab on assumptions on biology and data made by different #DrugSynergy models. This is critical when choosing the right synergy model for your data! sciencedirect.com/science/articl…

@houndcl @VICB_Vanderbilt @cispt2 @CellPressNews @quarantalab @ceelox4 Thanks @houndcl for your kind words. I am the beneficiary of a great consortium of scientists, including yourself, who go to work every day trying their best to make the world a better place. "If I have seen further, it is by standing on the shoulders of Giants." -Newton

Carlos Lopez & Vito Quaranta tackle issues impacting all aspects of combination therapy discovery and deployment in this CellPress review article titled "Charting the Fragmented Landscape of Drug Synergy" bit.ly/2Im7VUN @CellPressNews @quarantalab @ceelox4 @meyerct6